0001973141-23-000359.txt : 20231220 0001973141-23-000359.hdr.sgml : 20231220 20231220161623 ACCESSION NUMBER: 0001973141-23-000359 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231220 DATE AS OF CHANGE: 20231220 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MoonLake Immunotherapeutics CENTRAL INDEX KEY: 0001821586 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39630 FILM NUMBER: 231501493 BUSINESS ADDRESS: STREET 1: DORFSTRASSE 29 CITY: ZUG STATE: V8 ZIP: 6300 BUSINESS PHONE: 41 41 510 8022 MAIL ADDRESS: STREET 1: DORFSTRASSE 29 CITY: ZUG STATE: V8 ZIP: 6300 FORMER COMPANY: FORMER CONFORMED NAME: Helix Acquisition Corp DATE OF NAME CHANGE: 20200818 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Bodenstedt Matthias CENTRAL INDEX KEY: 0001920545 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: DORFSTRASSE 29 CITY: ZUG STATE: V8 ZIP: 6300 144 1 primary_doc.xml 144 0001920545 XXXXXXXX LIVE 0001821586 MoonLake Immunotherapeutics 001-39630 DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022 Bodenstedt Matthias Officer CFO Common UBS Financial Services, Inc.

1000 Harbor Blvd 3rd Floor Weehawken NJ 07086

5264 311997.00 59940529 12/20/2023 Nasdaq Common 04/05/2023 Exchange of share Issuer N 5264 04/05/2023 Cash N Matthias Bodenstedt

DORFSTRASSE 29 ZUG V8 6300

Common 12/19/2023 94736 5610265.92 12/20/2023 09/19/2023 /s/ UBS Financial Services Inc, as attorney-in-fact for Matthias Bodenstedt